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reperfusion; substrate; metabolism; perfused heart; ruthenium red IN RECENT YEARS evidence has accumulated that metabolism of exogenous glucose early during reperfusion favorably influences recovery of postischemic myocardium (22, 42) . Identification of the subcellular mechanism(s) responsible for the beneficial effects of glucose metabolism is complicated by the multiple fates of glucose taken up by the myocardium, which include incorporation into glycogen, anaerobic glycolysis to lactate, mitochondrial oxidation, and oxidation in the pentosephosphate pathway (6) . A number of observations suggest a crucial role of activation of pyruvate dehydrogenase (PDH) for the protective effect of glucose (19) . PDH largely controls the rate of entry of pyruvate into mitochondrial oxidative catabolism by the tricarboxylic acid cycle. It has been proposed (39) that oxidation of glycolytically produced pyruvate avoids the production of protons during anaerobic glycolysis to lactate and thereby reduces myocyte calcium overload caused by successive transsarcolemmal H ϩ / Na ϩ and Na ϩ /Ca 2ϩ exchange. Activity of PDH is reduced by phosphorylation, which is mediated by PDH kinase. The latter enzyme is activated by high levels of acetyl coenzyme A (acetyl-CoA) and NADH, as is observed in myocardium under conditions of high fatty acid oxidation (33), and is inhibited by dichloroacetate (35) . Conversely, PDH is activated by a calcium-sensitive PDH phosphatase (25) . Consistent with a protective effect of activation of PDH during reperfusion, enhancement of glucose oxidation and improvement of recovery of contractile function has been observed in postischemic hearts exposed to pyruvate (16) , dichloroacetate (27) , trimetazidine (43), L-carnitine (38) , and ranolazine (5).
However, the rationale for implementation of an intervention aimed at activation of PDH early during reperfusion depends on the level of spontaneous activity of PDH in postischemic myocardium. In fact, reported data on carbohydrate oxidation early during reperfusion exhibit considerable variability with increased (9) , unaltered (17, 20) , or decreased (14, 38) glucose oxidation compared with baseline values. This suggests that activity of PDH early during reperfusion critically depends on the selected experimental conditions. Specifically, in the experiments by Lopaschuks et al. (27) , in isolated working rat hearts perfused with medium containing 11 mM glucose and 1.2 mM palmitate, glucose oxidation rapidly returned to the preischemic level after 25-30 min of no-flow ischemia, which was markedly lower than in control hearts perfused with glucose as the sole substrate. This indirectly suggests persistent fatty acid-mediated inhibition of PDH during reperfusion. The concept of postischemic inhibition of PDH has been supported by 13 C magnetic resonance spectroscopy (16) or direct measurement of myocardial enzyme activity in isolated perfused rat hearts subjected to 10 or 20 min of no-flow ischemia (43) . In contrast to these findings, our group has observed in isolated rat hearts perfused with erythrocyteenriched medium containing 11 mM glucose and 0.4 mM palmitate pronounced stimulation of glucose oxidation early during reperfusion after 35-40 min of no-flow ischemia (1, 9) . Postischemic stimulation of myocardial glucose oxidation has also been observed in pigs (18, 26) and dogs (2, 31) after prolonged regional myocardial ischemia (Ͼ40 min). These data indirectly suggest that postischemic activation of glucose oxidation may increase with increasing severity of ischemic injury.
In the present study, we sought to determine in isolated perfused rat hearts 1) the influence of the degree of ischemic injury on myocardial activity of PDH, and 2) the potential role of myocardial mitochondrial calcium uptake in the anticipated postischemic activation of PDH.
MATERIALS AND METHODS

Animals
This study was approved by the institutional ethical committee for animal experiments and was conducted in accordance with the "Guiding Principles in the Care and Use of Animals" published by the American Physiological Society. Experiments were performed in male OFA rats (Iffa Credo; L'Arbresle, France) weighing 280-350 g. Rats were fasted for 24 h before experimentation.
Heart Perfusion
Rats were anesthetized with thiopental sodium (Penthotal, 60 mg/kg ip; Abbott; Chicago, IL). After thoracotomy, heparin (Liquemin, 1,000 IU; Roche; Basel, Switzerland) was injected into the inferior vena cava and the heart was quickly excised, placed in ice-cold saline, blotted, and weighed. The aorta was cannulated and retrograde perfusion was initiated at a constant flow (10 ml ⅐ min Ϫ1 ⅐ g wet wt Ϫ1 ) in a nonrecirculating system that included a roller pump (model IPS4, Ismatec; Glattbrugg, Switzerland). The initial perfusate was Krebs-Henseleit (KH) buffer containing (in mM) 118 NaCl, 4.0 KCl, 1.8 CaCl 2, 1.4 KH2PO4, 1.2 MgSO4, 25 NaHCO3, and 11 glucose. All perfusates were equilibrated with 95% O2-5% CO2 and warmed to 37°C. The pulmonary artery was cannulated for collection of the coronary effluent. Hearts were paced at 300 beats/min throughout the experiment. A fluidfilled latex balloon was inserted into the left ventricle via a left atriotomy and was connected to a Statham P21 XL pressure transducer (Gould; Valley View, OH). At the beginning of perfusion with erythrocyte-containing medium (described in the next paragraph), filling of the balloon was adjusted to give a left ventricular (LV) systolic pressure of 80 mmHg. The balloon volume was then kept constant throughout the experiment. Isovolumic LV diastolic and systolic pressures were recorded continuously on a strip-chart recorder (type 2400S; Gould). Developed LV pressure (DLVP) was calculated as the difference between LV systolic and diastolic pressures.
After surgical preparation, perfusion was changed to an erythrocyte-enriched KH medium (EE-KH) containing 11 mM glucose, 70 mU/l insulin (Actrapid; Novo Nordisk Pharma), and 0.4 mM palmitate bound to 0.4 mM albumin. Washed human erythrocytes were added to the perfusate to yield a hematocrit of 30% allowing sufficient O 2 supply to the myocardium at a physiological flow rate of 2 ml ⅐ min Ϫ1 ⅐ g wet wt Ϫ1 (9) . EE-KH was passed through a 10-m transfusion filter (MF10, Biotest; Othmarsingen, Switzerland) that was included in the perfusion system. At the end of the perfusion protocol, the heart was quickly frozen with an aluminum clamp precooled in liquid N 2, powdered with a pestle in a mortar filled with liquid N2, and stored at Ϫ80°C for subsequent biochemical analysis.
Perfusion Protocols
Control experiments. Hearts of this group (n ϭ 12) were perfused without intervention for 120 min at the control flow rate of 2 ml ⅐ min Ϫ1 ⅐ g wet wt Ϫ1 with EE-KH medium. Samples of the perfusate and the coronary effluent were withdrawn every 15 min. Radiolabeled substrates for metabolic measurements were present during the entire perfusion period. In additional hearts (n ϭ 3), ruthenium red was infused into the perfusion system starting 55 min after the onset of perfusion with EE-KH to yield a final perfusate concentration of 6 M. The infusion was continued for 40 min. During the last 20 min of the experiment, hearts were perfused without ruthenium red.
The commercially obtained ruthenium red batch (purity 33% wt/wt; Sigma) was purified by crystallization according to Luft (21) . Purified ruthenium red was dissolved in KH buffer at a concentration of 90-120 M, filtered (0.2 M), analyzed for ruthenium red concentration by spectrometry, and infused into a stirring chamber just proximal to the aortic cannula at a rate that resulted in a perfusate concentration of 6 M (1).
Effects of 20 min of ischemia. Hearts of this group (n ϭ 12) were first equilibrated for 20 min with EE-KH; thereafter, perfusion was stopped for 20 min. Immediately after perfusion was stopped, the coronary circulation was flushed with 3 ml of erythrocyte-free perfusate to prevent intracoronary aggregation of erythrocytes. During ischemia, the heated jacket surrounding the heart was filled with warmed KH to maintain the myocardial temperature at 37°C. Hearts were then reperfused for 60 min at the control flow rate (2 ml ⅐ min Ϫ1 ⅐ g wet wt Ϫ1 ). Samples of the perfusate and the coronary effluent were collected after 10 and 20 min of equilibration and 5, 15, 30, 45, and 60 min after the onset of reperfusion.
Effects of 35 min of ischemia. The perfusion protocol of this group of hearts (n ϭ 11) was identical to that of the 20-min ischemia group, with the exception that perfusion was stopped for 35 min. The duration of ischemia was selected based on previous observations that indicated pronounced stimulation of glucose oxidation (42) . Although low-flow ischemia more closely simulates evolving myocardial infarction in vivo, we have previously observed (9) that the limited duration of stability of in vitro perfused hearts does not allow for extending the ischemic period long enough to reproducibly induce irreversible injury in the presence of residual perfusion.
Effects of ruthenium red after 35 min of ischemia. The same ischemia-reperfusion protocol was followed as in the hearts of the 35-min ischemia group. However, ruthenium red was infused into the perfusion system during the initial 40 min of reperfusion to yield a final concentration of 6 M (n ϭ 6).
Analytic Procedures
Myocardial O 2 consumption. Hemoglobin content and O2 saturation of hemoglobin in both the perfusate and coronary effluent were measured with an oximeter (type IL282; In-strumentation Laboratory; Lexington, KY), and PO2 and pH were measured with a blood gas analyzer (type IL1304; Instrumentation Laboratory). Myocardial O2 consumption was calculated by multiplying the difference of the total O 2 content (hemoglobin-bound and dissolved O2) between perfusate and coronary effluent by the myocardial blood flow (9 ) by the specific activity of the labeled substrate in the perfusate (in cpm/nmol).
14 CO2 was measured in the perfusate and the coronary effluent as described previously (9) . In brief, 1-ml samples were injected into sealed flasks containing 1 ml of 2 M NaOH. CO 2 was released by addition of 3 ml of 1 M H 2SO4 and trapped on small pieces of filter paper soaked with 250 l of hyamine hydroxide (NCS; Amersham). The filter paper was then counted by liquid scintillation in a ␤-spectrometer (LS 7500; Beckman Instruments; Irvine, CA) (1, 9).
Myocardial glycolytic flux was estimated based on myocardial release of 3 H2O from [5-3 H]glucose added to the perfusate. Samples of the perfusate and the coronary effluent (0.5 ml) were deproteinized with 1 ml of 0.6 M HClO4 immediately after withdrawal and were neutralized with 75 l of 5 M K2CO3. Tritiated water was separated from H]glucose by anion-exchange chromatography on Dowex-1-borate columns (11) . Dowex 1 ϫ 4 resin (chloride form, 200-400 mesh) was converted to Dowex-1-borate by washing with 0.05 M K2B4O7. Deproteinized samples (0.2 ml) were loaded onto a 0.5-ml volume bed of resin and eluted with 0.8 ml of H 2O into scintillation vials. Analysis of standard solutions containing known amounts of 3 H2O and [U-14 C]glucose revealed that Ͼ99% of the labeled glucose and Ͻ5% of labeled water was retained by the column.
Creatine kinase. The coronary effluent was collected during the entire postischemic reperfusion period for the determination of cumulative myocardial release of creatine kinase (CK NAC kit; bioMérieux; Marcy-l'Etoile, France) (41) .
PDH activity. Myocardial PDH activity was measured in additional hearts of each perfusion protocol by the procedure described by McCormack and Denton (23) . Hearts were freeze-clamped after 20, 60, or 120 min of control perfusion or after 5 and 60 min of postischemic reperfusion. Frozen samples (100-200 mg) were homogenized in buffer (100 mM potassium phosphate, 2 mM EDTA, and 1 mM dithiothreitol) containing 0.1% (wt/vol) Triton X-100 and 50 l/ml of rat serum to stabilize the enzyme. Samples were centrifuged at 10,000 g for 2 min. The active form of PDH (PDHa) was assayed immediately by spectrophotometry (model LS 7500; Beckman Instruments; Irvine, CA). An aliquot of 100-200 l of the supernatant was added to a cuvette containing 1.5 ml of buffer (100 mM Tris ⅐ HCl and 1 mM MgSO4 at pH 7.8), 20 l/ml p-(p-aminophenylazo)benzenesulfonic acid (AABS), 0.2 l/ml mercaptoethanol, 50 l of substrate mix, and 20 l of arylamine acetyltransferase (AAT; EC 2.3.1.5; 60-100 mU). The substrate mix contained (in mM) 78 thiamine pyrophosphate, 34 NAD ϩ , 80 pyruvate, and 9.8 acetyl-CoA dissolved in 1 ml of H 2O. The acetylation of the AABS was established spectrophotometrically at 460 nm. Total amount of PDH (PDHt) was obtained by incubating the cardiac homogenate with PDH phosphatase isolated from the pig heart and incubated with calcium (1 mM) and magnesium (20 mM) during 30 min at 30°C before centrifugation. Supernatant (50 l) was added to the reaction cuvette described above. The activation state, i.e., percent active PDH, was calculated as (PDHa/PDHt) ϫ 100. PDH phosphatase was prepared from freshly removed pig hearts as described by McCormack and Denton (24) . The final preparation of PDH phosphatase was free of detectable PDH activity. Total protein concentration was determined spectrophotometrically at 595 nm using the Bradford method (Bio-Rad; Munich, Germany) (3).
Statistical Analysis
Results are presented as means Ϯ SD. Data of myocardial metabolism and contractile function were analyzed by unpaired t-test for repeat measurements. Cumulative release of creatine kinase and PDH activity were analyzed by unpaired t-test. Statistical tests were conducted using StatView II software for Apple Macintosh (Abacus Concepts; Berkeley, CA). Differences were considered significant at P Ͻ 0.05. Figure 1 depicts LV diastolic pressure, DLVP, and myocardial O 2 consumption of control hearts and hearts subjected to either 20 or 35 min of no-flow ischemia. In control hearts, contractile function was stable throughout the 120-min observation period. DLVP averaged 78 Ϯ 2.3 mmHg after 10 min of perfusion with EE-KH and 82.5 Ϯ 3.4 mmHg after 120 min (see Fig. 1 ).
RESULTS
Effect of Ischemia And Reperfusion on Myocardial Contractile Function, O 2 Consumption, and Release of Creatine Kinase
Hearts subjected to 20 min of no-flow ischemia exhibited only a slight increase of LV end-diastolic pressure at the end of the ischemic period (8.0 Ϯ 0.9 vs. 0.1 Ϯ 0.2 mmHg in control hearts; P ϭ not significant), which returned to baseline during reperfusion. DLVP recovered rapidly after the onset of reperfusion and averaged 83% of the corresponding value of control hearts after 5 min and 99% after 60 min. Myocardial O 2 consumption returned to baseline within 5 min after the onset of reperfusion and remained constant thereafter. Myocardial release of creatine kinase was low during reperfusion after 20 min of no-flow ischemia and did not significantly differ from control hearts (see Fig. 2 ).
Hearts subjected to 35 min of no-flow ischemia developed marked diastolic contracture later than 20 min after the onset of ischemia with LV diastolic pressure averaging 52 Ϯ 2.3 mmHg at the end of the ischemic period (P Ͻ 0.01 vs. control hearts). LV diastolic pressure did not decrease during the 60-min reperfusion period. Recovery of DLVP was incomplete, averaging after 60 min of reperfusion 37% of the value measured in the control group (P Ͻ 0.01). Despite poor recovery of contractile function, myocardial O 2 consumption rapidly returned to baseline and 5 min after the onset of reperfusion averaged 98% of the value measured in the control group (P ϭ not significant). Myocardial O 2 consumption subsequently gradually decreased to 59.8% of control after 60 min (P Ͻ 0.01). Cumulative myocardial release of creatine kinase during reperfusion was increased sixfold compared with control hearts (P Ͻ 0.01; see Fig. 2 ).
Glucose Oxidation, Glycolytic Rate, and Lactate Oxidation During Postischemic Reperfusion
During reperfusion after 20 min of no-flow ischemia, glucose oxidation did not differ from values measured in control hearts (see Fig. 3 ). In contrast, in hearts subjected to 35 min of no-flow ischemia without intervention, glucose oxidation was increased sevenfold compared with control hearts at 15 min after the onset of reperfusion (see Fig. 3 ). Glucose oxidation subsequently gradually returned toward baseline but was still slightly elevated after 60 min.
In contrast to glucose oxidation, the glycolytic rate did not significantly differ from that of control hearts after both 20 min and 35 min of ischemia (see Fig. 4 ).
Because oxidation of lactate more closely reflects activity of PDH than glucose oxidation, myocardial oxidation of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]lactate was measured in additional experiments. Similar to oxidation of glucose, myocardial oxidation of lactate was not altered in hearts reperfused after 20 min of no-flow ischemia but was , and myocardial O2 consumption (C) in control hearts (E, n ϭ 12), hearts subjected to 20 min of ischemia (}, n ϭ 12), hearts subjected to 35 min of ischemia (s, n ϭ 11), and hearts subjected to 35 min of ischemia and subsequently reperfused with ruthenium red (RR)-containing medium (OE, n ϭ 6). Isolated rat hearts were perfused in a retrograde manner with erythrocyteenriched Krebs-Henseleit buffer containing 0.4 mM palmitate and 11 mM glucose. Ruthenium red was administered during the initial 40 min of reperfusion. Values are means Ϯ SD. *P Ͻ 0.05 vs. control hearts; **P Ͻ 0.01 vs. control hearts; ϩP Ͻ 0.05 and ϩϩP Ͻ 0.01 vs. hearts subjected to 35 min of ischemia. 3 . Time course of myocardial oxidation of glucose in control hearts (E, n ϭ 6), hearts subjected to 20 min of no-flow ischemia (}, n ϭ 7), and hearts subjected to 35 min of no-flow ischemia and reperfused without (s, n ϭ 6) and with (OE, n ϭ 6) ruthenium red. Hearts were perfused as described for markedly increased during reperfusion in hearts subjected to 35 min of no-flow ischemia (see Fig. 5 ).
Myocardial Activity of PDH
Total PDH activity after enzymatic dephosphorylation was comparable among the control group, the 20-min ischemia group, and the 35-min ischemia group (4.9 Ϯ 1.7, 5.2 Ϯ 1.1, and 4.0 Ϯ 0.8 nmol ⅐ min Ϫ1 ⅐ mg protein Ϫ1 , respectively; values measured after 60 min control perfusion or 5 min after the onset of reperfusion). In control hearts, the proportion of active PDH complex averaged 13.4 Ϯ 6.3% at the end of 20 min of equilibration with EE-KH and remained stable throughout the perfusion protocol (18.0 Ϯ 11.0% after 120 min of perfusion).
Five minutes after the onset of reperfusion after 20 min of no-flow ischemia, the active fraction of the PDH was modestly but significantly increased to 38.0 Ϯ 12.3% (P Ͻ 0.05; Fig. 6A ). Activation of PDH was entirely reversible after 60 min of reperfusion (see Fig.  6B ).
In hearts subjected to 35 min of no-flow ischemia there was a sixfold increase in the active PDH fraction 5 min after the onset of reperfusion to 72.8 Ϯ 15.2% (P Ͻ 0.01; Fig. 6A ). PDH activity decreased during the reperfusion period but still averaged 52.0 Ϯ 18.6% after 60 min (P Ͻ 0.01; Fig. 6B ).
Effects of Ruthenium Red
To determine the potential involvement of mitochondrial calcium uptake in the activation of PDH after 35 min of no-flow ischemia, ruthenium red (6 M) was added to the perfusate to block the mitochondrial Ca 2ϩ uniporter at the inner mitochondrial membrane. In nonischemic control hearts (n ϭ 3), ruthenium red exerted a pronounced negative inotropic effect with a reduction in DLVP after 30 min of exposure by 45% (P Ͻ 0.01). Myocardial O 2 consumption was reduced by 61% from 3.3 Ϯ 0.2 to 1.2 Ϯ 0.7 nmol ⅐ min Ϫ1 ⅐ g wet wt
Ϫ1
(P Ͻ 0.01), and oxidation of glucose was reduced by 62% from 18.2 Ϯ 6.0 to 6.9 Ϯ 4.4 nmol ⅐ min Ϫ1 ⅐ g wet wt Ϫ1 (P Ͻ 0.05). Consistent with previous observations from our laboratory (1), ruthenium red markedly reduced diastolic contracture and improved recovery of contractile function during reperfusion in hearts subjected to 35 min of no-flow ischemia (see Fig. 1 ). Specifically, LV diastolic pressure steadily decreased during ruthenium red infusion to 12.2 Ϯ 8.0 mmHg (P Ͻ 0.05 vs. control hearts) at the end of the 40-min infusion and only slightly increased after cessation of ruthenium red infusion to 20.6 Ϯ 11.4 mmHg (vs. 60.2 Ϯ 9.7 mmHg in untreated postischemic hearts; P Ͻ 0.01).
DLVP recovered completely during ruthenium red infusion and remained high after cessation of ruthenium red administration (84.1 Ϯ 9.5 mmHg at the end of the observation period; P ϭ not significant vs. control hearts). Finally, cumulative myocardial release of creatine kinase was reduced by ruthenium red and did not differ significantly from control hearts.
Myocardial O 2 consumption was slightly lower early during reperfusion in the presence of ruthenium red compared with untreated postischemic hearts despite higher contractile function, which indicates enhancement of metabolic efficiency (see Fig. 1 ). Ruthenium red did not alter glycolytic flux (see Fig. 4 ). However, glucose oxidation was markedly reduced during reperfusion by ruthenium red compared with untreated hearts subjected to 35 min of no-flow ischemia (by 55.7% after 15 min of reperfusion; Fig. 3 ). By 30 min of reperfusion, glucose oxidation in the ruthenium redtreated hearts did not differ significantly from nonischemic control hearts.
Ruthenium red completely abolished postischemic activation of PDH in hearts subjected to 35 min of no-flow ischemia (see Fig. 6 ). Relative PDH activity closely matched the corresponding values in nonischemic control hearts after 5 min (14.3 Ϯ 6.0 vs. 13.4 Ϯ 5.8%; P ϭ not significant) and 60 min (14.0 Ϯ 11.4 vs. 18.6 Ϯ 11.0%; P ϭ not significant) of reperfusion.
DISCUSSION
There is increasing evidence that activity of PDH early during reperfusion may critically influence recovery of postischemic myocardium (27) . In this study, we measured in isolated rat hearts perfused with fatty acid-containing medium the effect of increasing degrees of ischemic injury on myocardial glucose oxidation and activity of PDH during reperfusion. The main findings are the following: 1) PDH is largely inhibited in hearts isolated from fasted rats and perfused with 11 mM glucose and 0.4 mM palmitate; 2) PDH is activated after transient ischemia, whereby the degree and duration of activation increases with increasing severity of the ischemic insult; and 3) pronounced activation of PDH in advanced ischemic injury seems to be related to mitochondrial calcium uptake.
Characteristics of the Model
To identify activation of PDH during postischemic reperfusion, experimental conditions were selected to maintain low baseline activation during perfusion without intervention. This was achieved by fasting the rats for 24 h before experimentation and inclusion of a physiological concentration of palmitate (0.4 mM) in the perfusate. Accordingly, the proportion of active PDH was low (13.4 and 18.0% after 20 min and 120 min of perfusion, respectively) in control hearts perfused for 120 min without intervention. We have previously observed in this model (29) that fasting results in high fatty acid oxidation rates and low glucose oxidation. The concomitant increase of myocardial acetyl-CoA content in the latter experiments (29) most likely contributed to inhibition of PDH by stimulation of PDH kinase-mediated phosphorylation.
Twenty minutes of no-flow ischemia resulted in entirely reversible postischemic injury on the basis of complete recovery of both contractile function and oxidative metabolism and the absence of excess creatine kinase release compared with control hearts. In contrast, 35 min of no-flow ischemia most likely resulted in a mixture of reversible and irreversible injury indicated by marked diastolic contracture, incomplete recovery of DLVP, and enhancement of release of creatine kinase. It is likely that myocardial injury was aggravated early during reperfusion because ventricular contracture and enzyme release were markedly reduced by ruthenium red, which was administered exclusively during the initial 40 min of reperfusion.
Consistent with previous observations (9, 30) , reperfusion after 35 min of ischemia resulted in complete recovery of myocardial O 2 consumption early after restoration of perfusion despite persistent depression of contractile function, which suggests reduced efficiency of oxidative metabolism in terms of contractile function (9, 30) . Because efficiency of oxidative metabolism was normalized by ruthenium red [an inhibitor of the mitochondrial calcium uniporter (4)], contraction-independent stimulation of the respiratory chain seems to be related to increased calcium concentration in the mitochondrial matrix (37) . At least two possible mechanisms of stimulation of oxidative metabolism by mitochondrial calcium uptake may be considered: 1) dissipation of respiratory energy by calcium-induced mitochondrial permeability pore transition (8, 40) may enhance metabolism; and 2) oxidative metabolism may be accelerated by activation of calcium-sensitive dehydrogenases in the tricarboxylic acid cycle, including isocitrate dehydrogenase and oxoglutarate dehydrogenase (24, 32) . postischemic reperfusion. However, the extent and duration of activation critically depend on the degree of the preceding ischemic insult: the active fraction of PDH was increased to 38.0% after 20 min of no-flow ischemia and to 72.8% after 35 min of no-flow ischemia. Activation of PDH was completely reversible after 60 min of reperfusion after 20 min of ischemia, whereas PDH activity remained elevated throughout the entire reperfusion period after 35 min of ischemia. Thus far, only a few studies have directly measured PDH activity in reperfused myocardium by tissue analysis. Consistent with the results of the present study, Pepe and colleagues (34) have recently observed a threefold increase of the active fraction of PDH in isolated rat hearts reperfused for 5 min after 15 min low-flow ischemia with medium containing 11 mM glucose and 0.2 mM octanoate. To our knowledge, PDH activity has not been measured during reperfusion after prolonged ischemia leading to stimulation of glucose oxidation.
In contrast to the present study, Kobayashi and Neely (13) have observed a reduction of PDH activity early during reperfusion. However, in their study, hearts were perfused with medium containing glucose as the sole substate, which resulted in a high baseline activation of PDH (exceeding 70% of total activity). Five minutes after the onset of reperfusion after 10 min of low-flow ischemia, the active fraction of PDH had dropped to ϳ60%, which is still higher than the value measured in the present study after 20 min of no-flow ischemia.
To examine the metabolic consequences of observed activation of PDH in this study, oxidation of either glucose or lactate (which more directly reflects activity of PDH) has been determined. Although PDH was slightly and transiently activated 5 min after the onset of reperfusion after 20 min of ischemia, neither glucose nor lactate oxidation was concomitantly increased. The reason for the dissociation between PDH activity and carbohydrate oxidation in reversibly injured postischemic myocardium is not apparent from the data of this study. However, it needs to be emphasized that substrate supply and accumulation of metabolic products may modulate flux through the PDH reaction independently of enzyme activity. In the present study, limited supply of pyruvate is unlikely to limit flux throughout PDH, because glycolytic flux was similar in hearts subjected to 20 or 35 min of ischemia. It is possible that the accumulation of acetyl-CoA and NADH that originated from fatty acid oxidation may have lowered flux throughout the PDH reaction despite the higher intrinsic activity of the enzyme. In fact, Kudo and colleagues (15) have shown in rat hearts that fatty acid oxidation is stimulated early during reperfusion.
Pronounced activation of PDH during reperfusion after 35 min of no-flow ischemia was associated with a marked increase of oxidation of both glucose and lactate. Enhancement of myocardial glucose oxidation during reperfusion has been observed previously after prolonged severe ischemia in isolated hearts (9, 26, 42) and animals in vivo (31, 36) . On the other hand, in working rat hearts reperfused after 25 to 30 min of no-flow ischemia with medium containing 11 mM glucose and 1.2 mM palmitate, glucose oxidation did not exceed preischemic levels, which is compatible with absent or less-pronounced activation of PDH (19, 20, 39) . This interpretation is indirectly supported by the marked stimulation of glucose oxidation in response to pharmacological activation of PDH by dichloroacetate (27) . The apparent absence of spontaneous stimulation of PDH during reperfusion in the latter studies may be related either to the lower severity of ischemic injury or the high fatty acid concentration in the perfusate.
Indirect Evidence for a Role of Mitochondrial Calcium Uptake in Postischemic Activation of PDH
Activation of PDH after 35 min of no-flow ischemia was completely abolished by the addition of 6 M ruthenium red to the perfusate at the moment of reperfusion. Because ruthenium red blocks the mitochondrial calcium uniporter (4), the results suggest that mitochondrial calcium uptake mediates postischemic activation of PDH by stimulation of PDH phosphatase. However, it needs to be emphasized that ruthenium red is not selective for blocking the mitochondrial calcium uniporter (12) ; in normal myocardium, this agent also inhibits sarcolemmal calcium binding and reduces release of calcium from the sarcoplasmic reticulum, which explains the negative inotropic effect observed in control hearts of this study (10) . Furthermore, recent evidence suggests that ruthenium red may directly interact with enzymes including smooth muscle myosin light chain phosphatase (44) . Although the precise mechanism of prevention of activation of PDH by ruthenium red is not known, indirect evidence suggests that reduction of mitochondrial calcium overload is involved. recently measured the effects of ruthenium red on mitochondrial calcium content by atomic absorption spectrometry. The authors observed an increase of calcium content in mitochondria isolated from perfused rat hearts submitted to 15 min of low-flow ischemia and a subsequent 5-min period of reperfusion. In these experiments, PDH was activated to a comparable extent as in the 20-min experiments of the present study. Increase of both mitochondrial calcium content and PDH activity were completely prevented by 3.4 M ruthenium red. Therefore, mitochondrial calcium uptake is likely to be involved in activation of PDH even after comparatively mild injury.
Glucose Oxidation and Myocardial Injury
A number of observations indicate that pronounced mitochondrial calcium overload is involved in the transition from reversible to irreversible myocardial injury early during reperfusion (7, 28) . Accordingly, irreversible injury and activation of PDH after 35 min of no-flow ischemia are likely to be epiphenomena of mitochondrial calcium overload. Therefore, activation of glucose oxidation is not necessarily implicated in the mechanisms that underlie irreversible myocardial injury. On the contrary, there is increasing evidence that activation of PDH improves myocardial recovery (16, 27, 43) . Consistent with this interpretation, we previously observed in rat hearts using the same perfusion protocol that withdrawal of glucose during reperfusion markedly aggravated myocardial contracture and enzyme release (42) . Furthermore, LV end-diastolic pressure was inversely related to glucose oxidation during reperfusion but not to the glycolytic rate (42) . This observation indirectly suggests that activation of PDH during reperfusion in severely injured myocardium is likely to counteract irreversible injury.
